Article

Leukemia Cutis in a Patient With Acute Myelogenous Leukemia: A Case Report and Review of the Literature

Author and Disclosure Information

Leukemia cutis is an infiltration of malignant neoplastic leukocytes or their precursors into the epidermis, dermis, or subcutis. These neoplastic cells are derived from abnormal leukocytes in the bone marrow where maturation aberrations occur. Acute myelogenous leukemia (AML) is the second most common cause of leukemia cutis and the most common leukemia among adults. In the elderly population, AML presents a challenge to the medical community because of the number of preexisting comorbid conditions and the safety profile of useful chemotherapeutic agents.


 

Recommended Reading

Dx of Stage III Melanomas Likely To Rise in 2010: New AJCC Staging Takes Effect Next Year
MDedge Dermatology
Mycophenolate Mofetil May Reduce SCC Risk After Transplant
MDedge Dermatology
Agent Targeting BRAF Mutations Shows Promise
MDedge Dermatology
Panel Backs Peginterferon for Stage III Melanoma
MDedge Dermatology
AAD Seal Program Off to a Slow Start
MDedge Dermatology
Evidence Helps Refine Melanoma Management
MDedge Dermatology
Bevacizumab's Melanoma Results Are Less Than Significant
MDedge Dermatology
Anti-TNF Agents May Up Skin Cancer Risk
MDedge Dermatology
Small-Diameter Melanomas: Diameter Does Not Matter [letter]
MDedge Dermatology
Pulmonary Cutaneous Metastasis: A Case Report and Review of Common Cutaneous Metastases
MDedge Dermatology